Background Extended-spectrum β-lactamase-producing Escherichia coli isolates (ESBL-E coli) cause more than 5000 cases of bacteraemias annually in the UK. The contribution of the food chain to these infections is debated. We aimed to identify the most important reservoirs of ESBL-E coli that colonise and infect humans to identify strategic intervention points.
Introduction
Escherichia coli is a Jekyll and Hyde organism; a few lineages are virulent enteropathogens whereas most are innocuous gut commensals that are harmful only if they reach other body sites-notably the urinary tract, where E coli is the most common pathogen. Most E coli urinary tract infections are uncomplicated cystitis, but some can ascend, affecting the kidneys and-at worst-causing overspill bacteraemia. Although such sequelae are rare, E coli is now the most common bloodstream pathogen in England, with 41 060 cases in the 2017-18 fiscal year, which was 27% more than in 2012-13 (32 309 cases). 1 Most E coli bacteraemias have a urinary origin 2 and, in the UK, about 60% are caused by extraintestinal these milieux and humans is uncertain, with the role of the food chain under debate. [10] [11] [12] A meta-analysis 10 identified six studies suggesting food-to-human trans-mission of ESBL-E coli against 17 finding foodborne transmission was unimportant. We aimed to clarify the contribution of foodborne ESBL-E coli to human colonisation and infection, using whole-genome sequencing to compare isolates from multiple sources across the UK.
Methods

Study design
We examined ESBL-E coli from multiple sources, including human faeces, sewage, farm slurry, live foodproducing animals, and raw meat, fruit, and vegetables. By comparing the bacteria from all of these reser voirs with ESBL-producing E coli from bloodstream infections in five regions of the UK, we sought to provide a comprehensive national map and to identify important reservoirs of the strains causing human disease in order to propose strategic intervention points to reduce the burden of ESBL-E coli in the UK.
Consecutive bloodstream ESBL-E coli isolates were collected between Jan 1, 2013, and Oct 12, 2014 from NHS laboratories in five UK regions, with five sites in East Anglia, two each in northwest England, Scotland, and Wales, and one in London. Identification and susceptibility testing were done according to laboratories' local protocols, with presumptive ESBL-E coli sent to Public Health England Colindale to a quota of 80 per region, along with brief, anonymised, patient details.
Isolates from other sources (human faeces, sewage, farm slurry, and retail foodstuffs) were collected prospectively in the five regions. Isolation involved plating samples onto CHROMagar ESBL and CHROMagar CTX (CHROMagar, Paris France) chromogenic media, prepared according to the manufacturer's directions. For human faecal sampling, which was decentralised, media were prepared at PubIic Health England Colindale and distributed weekly to laboratories. Characterisation of presumptive ESBL-E coli was centralised at PubIic Health England Colindale and the Animal and Plant Health Agency (APHA) Addlestone.
Human faeces
Faecal specimens were submitted between Aug 12, 2013, and July 20, 2014, for detection of intestinal pathogens or occult blood screening at Barts Health (London), the Norfolk & Norwich University Hospital (East Anglia), Lancashire Hospitals Trust, Central Manchester University Hospitals (northwest England), Aneurin Bevan University Health Board (Wales), and NHS Greater Glasgow and Clyde (Scotland). Each laboratory was asked to randomly select and test 15-20 faecal specimens per day to a maximum of 100 per week. No guidance was given on how to select randomly.
Faeces (about 0·5 g) was mixed with 1 mL of 0·85% saline, then 50-µL aliquots were spread on the two chromogenic agars and incubated for 18-24 h. Presumptive ESBL-E coli (visible as pink on CHROMagar ESBL or blue on CHROMagar CTX) were retained.
Sewage
Paired inflow and effluent sewage samples (50-1000 mL) were obtained from multiple sewage works belonging to
Research in context
Evidence before this study Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-E coli) are the largest group of multidrug-resistant pathogens from bacteraemias in the UK, presenting major challenges. E coli is also the major aerobic component of the human and animal gut biota and is a frequent contaminant of meat and the environment. Extensive literature reviews in 2011-12 were summarised in a joint 2012 report of ESBL-E coli by UK Government Advisory Committees. This, and subsequent publications, reported considerable uncertainly on the contribution of foodborne and environmental ESBL-E coli to human colonisation and invasive infection. For example, early Dutch studies suggested some similarities between ESBL-E coli from humans and poultry farming, whereas a larger subsequent study covering the UK, the Netherlands, and Germany did not support such a link. A meta-analysis identified six studies suggesting food-to-human transmission of ESBL-E coli versus 17 that argued against this view. These uncertainties led to the start of a competitive NIHR Policy Research Programme and, among various activities, this programme funded the present comparison of ESBL-E coli from human and animal sources.
Added value of this study
This study shows that the ESBL-E coli strains from bacteraemias in the UK match those prevalent as human gut colonists and in sewage. However, with respect to strain and ESBL types, they are largely distinct from those in food animals and retail food.
Implications of all the available evidence
In 2016, the UK Government announced its aim to achieve a 50% reduction in serious Gram-negative infections by 2020. A reduction in the numbers of infections due to ESBL-E coli is especially desirable, given their incidence (>5000 cases per year) and the treatment challenges. Our findings show that actions on the food chain, however desirable for animal husbandry, are unlikely to contribute to reductions in human infection. Better potential control points are prevention of transmission by good post-toilet hygiene (eg, in care homes) and prevention of severe infection through good patient care and rapid effective treatment of initial uncomplicated urinary tract infections, which precipitate most of the bacteraemias. Vaccines might also be a future solution.
four water companies covering Scotland, northwest England, London, and Wales. East Anglia did not participate. Each region provided four batches of samples between Dec 9, 2013, and Dec 15, 2014, with about 80 samples per region. Samples were couriered to PubIic Health England Colindale at 2-8°C, stored at 2-10°C, and processed within 24 h. Volumes (0·01-10 mL) were filtered through 0·45-µm pore membranes, which were washed with distilled water before transfer to absorbent pads saturated with lauroyl sulphate broth for 4 h at 30°C, then to lauroyl sulphate agar for 14 h before enumeration of yellow colonies as presumptive E coli. Lastly, one filter per sample was transferred to each CHROMagar and incubated at 37°C for 18-24 h. Colonies that continued to develop, becoming appropriately coloured for ESBL-E coli, were retained at 4°C.
Sewage samples were stored for further analysis by pelleting bacteria from about 30 mL sewage, resuspended in 0·5 mL of freezing broth and retained at -70°C. Putative ESBL-E coli were recovered, as red colonies, after plating 100 µL of defrosted material on UTI Brilliance Agar (Oxoid, Basingstoke, UK) containing 10 mg/L of cefotaxime.
Food
The methods and corresponding results for food isolates have been published previously. 13 We bought the following in each of the five regions: beef, pork, and chicken (n=397 samples in a 2:1:2 ratio, reflecting market share), grapes (n=50), strawberries (n=38), raspberries (n=35), blueberries (n=27), celery (n=50), carrots (n=50), onions or spring onions (n=50), lettuce (n=50), coriander (n=43), and basil (n=7). 13 Retailers included leading supermarkets, discount stores, convenience stores, and local butchers and greengrocers, in proportion to market share. Beef and chicken were obtained on five occasions between Aug 1, 2013, and Feb 28, 2014; pork on four occasions between Oct 1, 2013, and Feb 28, 2014; and vegetables on 15 occasions between Jan 1, and March 31, 2014. Meat samples were processed by the UK APHA; fruit, vegetables, and herbs were done by PubIic Health England, with the two chromogenic agars used to recover presumptive ESBL-E coli.
Slurry 97 slurry samples were collected from dairy farms across the five regions between Jan 13, and March 24, 2014, after milking and before cleaning. Samples were taken from five different areas at each farm on the route that the cows followed when leaving the milking parlour. London was represented by the Home Counties (Berkshire, Buckinghamshire, Essex, Hertfordshire, Kent, Surrey, and Sussex). 1-g samples were incubated overnight at 37°C in 9 mL of buffered peptone water before plating 10-µL amounts on the two chromogenic agars.
Veterinary diagnostic surveillance
We assessed veterinary diagnostic submissions to APHA or its predecessor laboratories from prospective sur-veillance across the five regions and from scanning surveillance of food animals. The latter entails laboratory investigations of animal disease, largely postmortem or through sample submission. Investigation aims to find the cause of disease, and E coli might be recovered and characterised. The isolates we studied comprised all ESBL-E coli submitted across the five regions during 2011-13, irrespective of their contribution to disease.
Characterisation of presumptive ESBL-E coli
Presumptive ESBL-E coli, isolated as explained from blood, faeces, sewage, food, animals and slurry were received at PubIic Health England and screened for bla CTX-M , bla TEM , bla SHV and bla OXA by multiplex PCR. 14 bla CTX-M -positive isolates were accepted as ESBL producers, whereas isolates that were positive for one of the other β-lactamase genes underwent double disc ESBL tests using amoxicillinclavulanate (20 μg + 10 μg) discs about 20 mm apart (centre to centre) from cefotaxime (30 μg), ceftazidime (30 μg), and cefepime (30 μg) discs. Expansion of an oxyiminocephalosporin zone towards the amoxicillin-clavulanate disc suggested ESBL production. 15 Isolates positive by these methods were confirmed as E coli by MALDI-ToF (Bruker Maldi-Biotyper, Bremen, Germany); any isolates flagged as shigella were confirmed as E coli based on o-nitrophenyl-β-Dgalactosidase activity and a 603-bp PCR product for ipaH. 16 Definitive confirmation as ESBL-E coli was done by wholegenome sequencing (HiSeq 2500; Illumina, San Diego, CA, USA). STs were assigned and β-lactamase genes sought using the in-house Genefinder pipeline. 17 ST131 isolates were assigned to clades based on fimH sequences. 18 Serotypes of ST10 isolates (which crossed among host species) were deduced from sequence data. 19 
Statistical analysis
Our analysis was primarily descriptive, with proportions shown as percentages and continuous variables as mean and SD. We used Pearson's χ² test to compare proportions. We used R (version 3.5.0) for all analyses.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
ESBL production was confirmed in 293 (90%) of 327 bloodstream isolates received as ESBL-E coli (table 1) . Case record forms were available for 244 (83%) of 293 isolates, with fewer forms available for London isolates (18 [33%] of 55; p<0·001). The mean age was 70 years (SD 18·7) overall, although participants were younger in London (58·9 years; Kruskal-Wallis rank sum test p=0·002). 240 (69%) of 347 patients with data were community presentations, or stayed in hospital for fewer than 48 h. Data on the origin of bacteraemia were available for 120 (49%) of 244 patients, with genitourinary (72 [60%] of 120) and gastrointestinal or hepatobiliary sources (22 [18%] of 120) being the most common. Few patients were identified as post-surgical (19 [9%] of 209 with data), but post-discharge re-presentations might be under-recorded. 20 243 faecal samples were screened, comprising 3995-4112 per region (table 2) . 2107 (10%) gave colonies of the appropriate colour for E coli on CHROMagar ESBL, 1302 (6%) on CHROMagar CTX, and 1252 (6%) on both. If appropriately coloured growth on either medium-as was true for 2157 (11%) of 20 243 faecal specimens-the samples were deemed to be positive. Regional ESBL prevalence was 8·5-9·8%, except for London, where prevalence was 17·0% (p<0·001; Results of screening foodstuffs have been published separately. 13 ESBL-E coli were recovered from 104 (65%) of 159 chicken samples, with positivity rates from 41% (13 of 32 samples in Scotland) to 81% (25 of 31 samples in northwest England; p<0·0001). Contamination could arise from the original bird or be acquired during slaughter and processing. Even with enrichment, only three (2%) of 159 beef samples and two (3%) of 79 pork samples yielded ESBL-E coli, based on growth on either of the two chromogenic agars. No ESBL-E coli were recovered from 400 fruit and vegetable samples, many of which were of international origin. [19] [20] dairy farm slurry samples were tested per region, with 27 (28%) of 97 samples positive for ESBL-E coli, based on growth on either medium. Regional rates ranged from 15% (three of 20 samples in Scotland) to 40% (eight of 20 samples in northwest England).
These prospective collections were supplemented with 83 ESBL-E coli from the APHA's scanning surveillance of food animals. These were from the same regions as the other series, with London again including the Home Counties; 51 isolates were from cattle, 29 from chickens with single isolates from other species.
ST131 greatly predominated in human bacteraemias, comprising 188 (64%) of 293 isolates. It was also the most prevalent ST, though less overwhelmingly so, in faeces (128 [36%] of 360 isolates) and sewage (14 [22%] of 65). Regional proportions of ST131 among bloodstream isolates were 36 (65%) of 55 in London, 40 (60%) of 66 in East Anglia, 29 (48%) of 61 in northwest England, 28 (76%) of 37 in Scotland, and 55 (74%) of 74 in Wales Other common bloodstream STs, in descending order of frequency, were 38, 648, 405, 73, 69, 636, 95, 1193, and 10. Several of these were also prominent in other humanrelated sources. STs 38, 405, 636, and 648 were among the top ten types among faecal isolates, with ST38 in second rank and ST648 in fourth; ST38 was the second ranked ST from sewage, followed by ST10. By contrast, the topranked STs from meat and animals were 602, 23, 117 (or its single locus variant ST6284), and ST10. Collectively, STs 23, 117, and 602 accounted for 68 (31%) of 218 foodderived and animal-derived ESBL-E coli samples collected, whereas ST10 accounted for 11 (22%) of 51 bovine ESBL-E coli samples. There was species specificity within the animal isolates, with STs 23 and 602 dominating for chickens and chicken meat, whereas STs 10, 117 and 6284 dominated in cattle and their slurry (table 3) .
The top-ranked human types were rare in meat, animals, and slurry. Just two ST131 isolates were recovered from animal-related sources: one from chicken meat and another from a surveillance chicken; both isolates belonged to ST131 clade B whereas over 95% of bloodstream, faecal, and sewage ST131 isolates belonged to clades C1 and (mostly) C2. STs 38, 648, 405, 73, 636, 95, and 1193 were not found in animal-associated sources, and ST69 was found in just one isolate from chicken meat and one from a cow. Only ST10, which accounted for 15 (4%) of 360 human faecal isolates and three (1%) of 293 isolates from blood was widely seen in bovines and their slurry, though not in meat (table 3) . This human and animal overlap for ST10 was more apparent than real; we found that 38 ST10 isolates belonged to 26 different combinations of O (somatic) and H (flagellar) serotype, with the three human bloodstream isolates and 12 (87%) of 15 human faecal isolates belonging to serotypes that were not seen from animal sources.
The predominant animal-related STs were infrequent in humans. ST602, the top ST from meat (specifically chicken), was not found in human bacteraemias and had only two representatives from human faeces. Among all 293 human bacteraemia isolates, only five (2%) belonged to top-ranked types from any animal-related source, specifically the three ST10 isolates and single representatives of STs 23 and 117.
CTX-M-15 enzyme was most common in human bloodstream, faecal, and sewage isolates (table 4) The only exception was ST10, for which CTX-M-1 was found in three (60%) of 15 human faecal isolates. The ST23/CTX-M-1 and ST602/CTX-M-1 combinations, which were widespread in chickens and their meat, were found only in single human faecal isolates and were never found in blood. CTX-M-14, the most frequent ESBL from the bovine isolates, was widely found in major human blood and faecal isolates, including ST131 and ST38, but the ST10/CTX-M-14 combination, frequent in cattle, had only single representatives from human faeces and blood, whereas ST117/ST6284 CTX-M-14 was not detected. There was a single bloodstream ST117 isolate with CTX-M-1 enzyme, matching a combination seen in ten isolates from chickens or their meat.
Discussion
We compared ESBL-E coli from human bacteraemias with those from human faeces, sewage, food, slurry, and animals across five regions in the UK. Bloodstream isolates followed expected patterns; they were mostly found in older patients with community-associated infection of genitourinary or gastrointestinal origin. 2 Faecal ESBL-E coli were often linked to foreign travel (particularly to south or southeast Asia) or previous use of antibiotics, which is consistent with the literature. 20, 21 Greater contamination of chicken than other meats concurs with previous findings. 22 Typing and ESBL results showed commonality between human bloodstream ESBL-E coli and those from faeces and sewage, with STs 131 (especially), 38, and 648 prominent in all these sources, largely with CTX-M-15 enzyme. There was also commonality between the lineages from surveillance chickens and chicken meat, with STs 23 and 602 dominating, often with CTX-M-1 ESBL, and between cattle and their slurry, where ST10 (with CTX-M-14 or CTX-M-15) dominated. There was little crossover between types from humans, chickens, and bovines, with only serotype diverse ST10 among the top ten most common types from humans, animals, and meat (figure). ST117 was widely found in isolates from both bovines and chickens. Little contamination was seen for foodstuffs other than chicken.
Our findings do not support the assertion that invasive ESBL-E coli are disseminating via the food chain. Rather, they suggest that host-adapted ESBL-E coli lineages are circulating, with infrequent interspecies transmission. This conclusion agrees with most studies included in a 2015 meta-analysis. 10 ST131, which dominated among human-related isolates, is well known and often multidrug resistant. 6, 23 Although ST131 occasionally occurs in food animals (as was seen in two instances in our analysis), the animal ST131 clades are generally different. 24 At the upper edge of the reported prevalence range, Johnson and colleagues 25 in the USA found five of 25 ESBL-E coli from chickens or chicken meat belonged to ST131. By contrast, we-and a previous investigation covering the UK, Germany, and the Netherlands 22found only occasional ST131 isolates from food and animals. This rarity is supported by a major review, 6 cataloguing many individual detections of ST131 from food or food animals, but no dissemination.
Other common types from bacteraemia-ST38 and ST648, each accounting for about 5% of cases versus 64% for ST131-were absent from food or animals. ST38 (with CMY-2, rather than ESBLs) has been found in poultry, humans, and wildlife; 26 ST648 is also largely reported from humans, although carriage was seen in horses and dogs. 27 Among the major meat and animal types, ST23 was reported from an outbreak in a French hospital, 28 with various further one-off reports but, as we report here, is mostly found in poultry, 29 as is ST117, 23 which has spread in Nordic broiler production. 30 ST602, although common in our study, has not been widely reported in previous studies. 22 ST10, as the sole lineage to appear in the top ten of both human bloodstream and meat-associated groups has been repeatedly noted by other studies 22 in both animals and humans. Nonetheless, the serotype diversity seen in our analysis argues against simple direct flows of ST10 along the food chain. Our results are consistent with those of a comparison of ESBL-E coli from human bacteraemias and livestock in the east of England, one of the regions we surveyed, which also found that these isolate groups and their resistance determinants are largely distinct. 31 Rather than the food chain, the human to human oralfaecal route is likely to be the most frequent route of transmission for human-adapted ESBL-E coli. This route would account not only for the strain and enzyme distributions we have summarised, but also the regional variation in gut carriage of ESBL-E coli with higher rates in London than elsewhere, where sampling was solely from the Royal London Hospital, which predominantly serves poor, crowded areas and populations with frequent travel to and from south Asia. A study in the West Midlands, UK, similarly showed that human gut carriage of ESBL-E coli was more prevalent in inner city conurbations (ie, around Birmingham) than in rural Shropshire. 32 We cannot exclude the possibility that some small minority of human infections might have a direct origin from food, nor that local clusters can occur. In Canada, 33, 34 near-identical ST131 and ST117 E coli (ESBL-producing or not) have been found in both retail chicken meat and human infections; nevertheless these putative crossovers accounted for only a small minority of all the human and animal E coli collected. Further, we cannot exclude the possibility that some future multidrug resistant E coli lineage from one or more food animal species will also prove adept at colonising and infecting humans. One further caveat remains: we do not know when, where, or how often bla CTX-M genes escaped from Kluyvera spp (where they are endogenous and chromosomal) to mobile DNA, nor the chain of transmission to human-adapted E coli lineages. However, it seems logical that the hazard of such gene escape will multiply with the range of animal species and intestinal microbiotas exposed to selective antibiotics. 35 Our findings suggest that efforts to stop the rise of ESBL-E coli in invasive infections should concentrate upon disrupting oral-faecal transmission by good posttoilet hygiene (eg, in care homes), on prevention of urinary tract infections by good hydration and catheter care, and on prompt effective treatment of preceding urinary tract infections. Vaccines could provide a solution in the future, with promising early results for cystitis in younger women. 36 Efforts to counter the spread of ESBL-E coli in food production seem unlikely to affect greatly the tally of invasive human infections but remain important in ensuring that veterinary infections remain tractable.
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